Chiaki Ishii

1.4k total citations · 1 hit paper
8 papers, 1.0k citations indexed

About

Chiaki Ishii is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Infectious Diseases. According to data from OpenAlex, Chiaki Ishii has authored 8 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 4 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Infectious Diseases. Recurrent topics in Chiaki Ishii's work include Monoclonal and Polyclonal Antibodies Research (4 papers), HER2/EGFR in Cancer Research (3 papers) and CAR-T cell therapy research (2 papers). Chiaki Ishii is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), HER2/EGFR in Cancer Research (3 papers) and CAR-T cell therapy research (2 papers). Chiaki Ishii collaborates with scholars based in Japan and Germany. Chiaki Ishii's co-authors include Toshinori Agatsuma, Yusuke Ogitani, Masako Soma, Tetsuo Aida, Hiromi Okamoto, Ryo Atsumi, Katsunobu Hagihara, Ichiro Hayakawa, Junko Yamaguchi and Masataka Oitate and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Chiaki Ishii

7 papers receiving 1.0k citations

Hit Papers

DS-8201a, A Novel HER2-Targeting ADC with a Novel DNA Top... 2016 2026 2019 2022 2016 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. DS-8201a, A Novel HER2-Targeting ADC with a Novel DNA Topoisomerase I Inhibitor, Demonstrates a Promising Antitumor Efficacy with Differentiation from T-DM1
    2016 767 citations Yusuke Ogitani, Tetsuo Aida et al. Clinical Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chiaki Ishii Japan 5 872 509 309 190 78 8 1.0k
Alexander H. Staudacher Australia 15 443 0.5× 355 0.7× 141 0.5× 225 1.2× 85 1.1× 33 780
Bradley M. Turner United States 14 440 0.5× 231 0.5× 197 0.6× 146 0.8× 19 0.2× 45 759
Gilles Gallant United States 9 530 0.6× 148 0.3× 302 1.0× 340 1.8× 118 1.5× 19 819
Masako Soma Japan 4 689 0.8× 413 0.8× 251 0.8× 159 0.8× 51 0.7× 5 790
Jürgen Wolf Germany 12 275 0.3× 67 0.1× 202 0.7× 208 1.1× 137 1.8× 25 605
Véronique Debien Belgium 10 406 0.5× 121 0.2× 156 0.5× 106 0.6× 91 1.2× 29 564
Vincent A. Pollack United States 9 423 0.5× 128 0.3× 228 0.7× 219 1.2× 78 1.0× 12 660
Whitney P. Kirschbrown United States 10 214 0.2× 104 0.2× 107 0.3× 111 0.6× 53 0.7× 16 416
Zhujun Jiang China 10 434 0.5× 183 0.4× 76 0.2× 148 0.8× 330 4.2× 16 689
Sandra Tomek Austria 11 263 0.3× 171 0.3× 189 0.6× 243 1.3× 62 0.8× 17 599

Countries citing papers authored by Chiaki Ishii

Since Specialization
Citations

This map shows the geographic impact of Chiaki Ishii's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiaki Ishii with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiaki Ishii more than expected).

Fields of papers citing papers by Chiaki Ishii

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chiaki Ishii. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiaki Ishii. The network helps show where Chiaki Ishii may publish in the future.

Co-authorship network of co-authors of Chiaki Ishii

This figure shows the co-authorship network connecting the top 25 collaborators of Chiaki Ishii. A scholar is included among the top collaborators of Chiaki Ishii based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiaki Ishii. Chiaki Ishii is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
2.
Ishii, Chiaki, et al.. (2018). A HER2-Targeting Antibody–Drug Conjugate, Trastuzumab Deruxtecan (DS-8201a), Enhances Antitumor Immunity in a Mouse Model. Molecular Cancer Therapeutics. 17(7). 1494–1503. 202 indexed citations
3.
Ishii, Chiaki, et al.. (2017). DS-8201a, a HER2-targeting antibody-drug conjugate, to elicit immune responses and benefits in combination with an anti-PD-1 antibody.. Journal of Clinical Oncology. 35(15_suppl). 1031–1031. 4 indexed citations
4.
Ogitani, Yusuke, Tetsuo Aida, Katsunobu Hagihara, et al.. (2016). DS-8201a, A Novel HER2-Targeting ADC with a Novel DNA Topoisomerase I Inhibitor, Demonstrates a Promising Antitumor Efficacy with Differentiation from T-DM1. Clinical Cancer Research. 22(20). 5097–5108. 767 indexed citations breakdown →
5.
Ogitani, Yusuke, Junko Yamaguchi, Chiaki Ishii, et al.. (2015). Abstract A145: DS-8201a, a novel HER2-targeting ADC with a novel DNA topoisomerase I inhibitor, demonstrates a potent anti-tumor efficacy with differentiation from T-DM1 in preclinical studies. Molecular Cancer Therapeutics. 14(12_Supplement_2). A145–A145.
6.
Higuchi, Saito, et al.. (2014). Anti-multidrug-resistant Acinetobacter baumannii activity of DS-8587: In vitro activity and in vivo efficacy in a murine calf muscle infection model. Journal of Infection and Chemotherapy. 20(5). 312–316. 4 indexed citations
7.
Yoshida, Kumi, et al.. (2010). In Vitro and in Vivo Antifungal Activities of Aminopiperidine Derivatives, Novel Ergosterol Synthesis Inhibitors. Biological and Pharmaceutical Bulletin. 33(3). 473–476. 6 indexed citations
8.
Ishii, Chiaki, et al.. (1995). Incidence of various gyrA mutants in 451 Staphylococcus aureus strains isolated in Japan and their susceptibilities to 10 fluoroquinolones. Antimicrobial Agents and Chemotherapy. 39(7). 1414–1418. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexander H. Staudacher Breakdown of academic impact, for papers by Bradley M. Turner Breakdown of academic impact, for papers by Gilles Gallant Breakdown of academic impact, for papers by Masako Soma Breakdown of academic impact, for papers by Jürgen Wolf Breakdown of academic impact, for papers by Véronique Debien Breakdown of academic impact, for papers by Vincent A. Pollack Breakdown of academic impact, for papers by Whitney P. Kirschbrown Breakdown of academic impact, for papers by Zhujun Jiang Breakdown of academic impact, for papers by Sandra Tomek
Rankless by CCL
2026